Potassium channel opener
This page covers all Potassium channel opener drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ATP-sensitive potassium channels, Kv7 (KCNQ) voltage-gated potassium channels, ATP-sensitive potassium channel (KATP).
Targets
ATP-sensitive potassium channels · Kv7 (KCNQ) voltage-gated potassium channels · ATP-sensitive potassium channel (KATP) · ATP-sensitive potassium channels (KATP) · ATP-sensitive potassium channel · KCNQ1
Marketed (6)
- minoxidil 5% solution · Allergan · Dermatology
Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle. - Ezogabine/Retigabine IR · GlaxoSmithKline · Neurology
Ezogabine opens voltage-gated potassium channels in neurons, reducing neuronal excitability and seizure activity. - KAD-1229 · Kissei Pharmaceutical Co., Ltd. · Cardiovascular
KAD-1229 is a potassium channel opener that relaxes vascular smooth muscle to reduce blood pressure. - Minoxidil Topical · Dr. dr. Lili Legiawati, SpKK(K) · Dermatology
Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle. - Minoxidil 5% Topical Solution · Triple Hair Inc · Dermatology
Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle. - KLH-2109 · Kissei Pharmaceutical Co., Ltd. · Cardiovascular
KLH-2109 is a potassium channel opener that relaxes vascular smooth muscle to reduce blood pressure.
Phase 3 pipeline (2)
- RSD1235 · Astellas Pharma Inc · Cardiovascular
RSD1235 is a potassium channel opener that suppresses atrial fibrillation by prolonging atrial refractoriness and reducing atrial conduction velocity. - Minoxidil Topical Foam · Eurofarma Laboratorios S.A. · Dermatology
Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.
Phase 2 pipeline (1)
- IMR-687 · Cardurion Pharmaceuticals, Inc. · Cardiovascular
Potassium channel opener